Go To Global Site
Welcome to UCB in the United States



UCB Engages Physicians to Meet Patients' Needs

Our recent launch of dynamic targeting in the U.S. is providing UCB a better grasp of physician needs, which can lead to better healthcare outcomes. This is a key building block in UCB’s digital transformation journey providing a proven blueprint and lessons learned to continue innovating now and in the future. This initiative was recognized as the Most Valuable Data and Insights Initiative at the Reuters Pharma Awards USA 2020. Read how UCB has improved efficiencies for our teams and helped evolve the field experience. The article was originally published by ZS.



Hackathon Brings Together Diverse Talents for Digital Innovation

As part of our Digital Business Transformation, UCB teams participated in a hackathon to improve the quality and efficiency of clinical study design and data analysis, ultimately a win for the patients we serve. Winners to be announced soon.



Embracing Digital Business Transformation to Accelerate Tailored Solutions for Patients

In a world where digital technology is significantly changing the way patients experience their care, UCB recognized the need for rapid integration of digital innovation into all aspects of business. Read from Emmanuel Caeymaex, Executive Vice President, Immunology Solutions and Head of U.S., on how UCB quickly adapted to the needs of patients and the ever-changing environment by embracing a digital business transformation.



UCB Unleashes the Power of Data in New Collaboration

UCB and Stanford Medicine have established a multi-year collaboration to enhance patient value for people living with severe diseases.



Expanded Relationship with Aetion Advances UCB’s Digital Business Transformation

UCB and Aetion announced a new agreement to advance UCB’s use of real-world evidence (RWE) using rapid and robust analytics.